142 related articles for article (PubMed ID: 28412736)
1. Tumor biology, clinicopathological characteristics and prognosis of screen detected T1 invasive non-palpable breast cancer in asymptomatic Chinese women (2001-2014).
Pan B; Yao R; Zhou YD; Zhu QL; Shi J; Xu QQ; Wang CJ; You SS; Mao F; Lin Y; Shen SJ; Liang ZY; Jiang YX; Sun Q
Oncotarget; 2017 Apr; 8(16):26221-26230. PubMed ID: 28412736
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and long-term prognosis of screening detected non-palpable breast cancer by ultrasound in hospital-based Chinese population (2001-2014).
Pan B; Yao R; Zhu QL; Wang CJ; You SS; Zhang J; Xu QQ; Cai F; Shi J; Zhou YD; Mao F; Lin Y; Guan JH; Shen SJ; Liang ZY; Jiang YX; Sun Q
Oncotarget; 2016 Nov; 7(47):76840-76851. PubMed ID: 27689334
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003-2017).
Pan B; Xu Y; Zhou Y; Yao R; Zhou X; Xu Y; Ren X; Xiao M; Zhu Q; Kong L; Mao F; Lin Y; Zhang X; Shen S; Sun Q
Breast Cancer Res Treat; 2022 Nov; 196(2):409-422. PubMed ID: 36166112
[TBL] [Abstract][Full Text] [Related]
4. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
[TBL] [Abstract][Full Text] [Related]
5. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
6. [Lymph node metastasis and prognostic analysis of 354 cases of T1 breast cancer].
Lyu Z; Wang J; Kang L; Hu C; He H; Guan M; Li J; Guan Y; Song Y
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):382-5. PubMed ID: 25030596
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification.
Ichizawa N; Fukutomi T; Iwamoto E; Akashi-Tanaka S
Jpn J Clin Oncol; 2002 Mar; 32(3):108-9. PubMed ID: 11956306
[TBL] [Abstract][Full Text] [Related]
8. Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.
Durak MG; Gonzalez-Angulo AM; Hanrahan EO; Broglio KR; Valero V; Hortobagyi GN; Hunt KK; Sahin AA
Breast J; 2011; 17(5):462-9. PubMed ID: 21726347
[TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
[TBL] [Abstract][Full Text] [Related]
10. Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes.
Chen L; Zhang J; Chen J; Liu L; Liang L; Shangguan Z; Wang D
Oncotarget; 2017 Jun; 8(26):42917-42925. PubMed ID: 28476034
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
12. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
14. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
16. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes.
Kim J; Lee S; Bae S; Choi MY; Lee J; Jung SP; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
[TBL] [Abstract][Full Text] [Related]
18. Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1-T2 tumor and 1-3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases.
Shen H; Zhao L; Wang L; Liu X; Liu X; Liu J; Niu F; Lv S; Niu Y
Tumour Biol; 2016 May; 37(5):6465-75. PubMed ID: 26631044
[TBL] [Abstract][Full Text] [Related]
19. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S
J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]